Widely used in pharmaceutical research, this compound serves as a key intermediate in the synthesis of immunomodulatory drugs. It plays a critical role in the development of cereblon E3 ligase modulators, which are a class of molecules known for their anti-inflammatory, anti-angiogenic, and antitumor properties. Due to its ability to selectively target specific proteins for degradation, it is employed in the design of proteolysis-targeting chimeras (PROTACs), enabling targeted protein degradation in cancer and other disease pathways. Its structural features make it valuable for optimizing drug candidates with improved potency and selectivity.